| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |